Two synthetic analogues of murine epidermal. growth factor, [Abu6, 20] mEGF4-48 (where Abu denotes amino-butyric acid) and [G1, M3, K21, H40] mEGF1-48, have been investigated by NMR spectroscopy. [Abu6, 20] mEGF4-48 was designed to determine the contribution of the 6-20 disulfide bridge to the structure and function of mEGF The overall structure of this analogue was similar to that of native mEGF, indicating that the loss of the 6-20 disulfide bridge did not affect the global fold of the molecule. Significant structural differences were observed near the N-terminus, however, with the direction of the polypeptide chain between residues four and nine being altered such that these residues were now located on the opposite face of the main beta...
The epidermal growth factor (EGF) receptor (EGFR) and the erbB-2 gene product, gp185erbB-2, exhibit ...
The extracellular domain of the epidermal growth factor (EGF) receptor (EGFR) comprises four subdoma...
Chemical or enzymic reduction/oxidation of integrin cysteine residues (e.g. by reducing agents and p...
AbstractThe role of leucine-47 in determining the structure and activity of human epidermal growth f...
The role of the B-loop region of epidermal growth factor (EGF) in mediating the recognition of this ...
AbstractSite-directed mutagenesis was employed to examine the function of two highly conserved resid...
The epidermal growth factors (EGFs) are powerful mitogens for a wide variety of cells in culture; hu...
<p>Epidermal growth factor (EGF) plays important roles in multiple biological processes, such as the...
Although binding of epidermal growth factor (EGF) and transforming growth factor ? (TGF?) to the EGF...
The solution structure of the growth factor chimera mEGF/TGF ?(44-50) has been determined using an e...
AbstractThe Ala-30 and Asn-32 residues involved in the major antiparallel β-sheet structure of human...
In this study the nature of binding of enhancing factor (EF) and its mode of action are examined. EF...
The mechanisms by which signals are transmitted across the plasma membrane to regulate signaling are...
Post-translational modifications (PTMs) of proteins induce structural and functional changes that ar...
Epidermal growth factor ( egf) domains are 30-50 residue long repeats characterized by the strict co...
The epidermal growth factor (EGF) receptor (EGFR) and the erbB-2 gene product, gp185erbB-2, exhibit ...
The extracellular domain of the epidermal growth factor (EGF) receptor (EGFR) comprises four subdoma...
Chemical or enzymic reduction/oxidation of integrin cysteine residues (e.g. by reducing agents and p...
AbstractThe role of leucine-47 in determining the structure and activity of human epidermal growth f...
The role of the B-loop region of epidermal growth factor (EGF) in mediating the recognition of this ...
AbstractSite-directed mutagenesis was employed to examine the function of two highly conserved resid...
The epidermal growth factors (EGFs) are powerful mitogens for a wide variety of cells in culture; hu...
<p>Epidermal growth factor (EGF) plays important roles in multiple biological processes, such as the...
Although binding of epidermal growth factor (EGF) and transforming growth factor ? (TGF?) to the EGF...
The solution structure of the growth factor chimera mEGF/TGF ?(44-50) has been determined using an e...
AbstractThe Ala-30 and Asn-32 residues involved in the major antiparallel β-sheet structure of human...
In this study the nature of binding of enhancing factor (EF) and its mode of action are examined. EF...
The mechanisms by which signals are transmitted across the plasma membrane to regulate signaling are...
Post-translational modifications (PTMs) of proteins induce structural and functional changes that ar...
Epidermal growth factor ( egf) domains are 30-50 residue long repeats characterized by the strict co...
The epidermal growth factor (EGF) receptor (EGFR) and the erbB-2 gene product, gp185erbB-2, exhibit ...
The extracellular domain of the epidermal growth factor (EGF) receptor (EGFR) comprises four subdoma...
Chemical or enzymic reduction/oxidation of integrin cysteine residues (e.g. by reducing agents and p...